New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 8, 2012
11:52 EDTPSTIPluristem lack of disclosure on patient death in legal gray area, Bloomberg says
Pluristem Therapeutics' (PSTI) stock soared and at least two top executives profited in spite of the fact that a patient reportedly died months after using its experimental stem cell treatment, according to Bloomberg. The company has yet to make an announcement of the girl’s death, which may put it in a legal gray area in regards to U.S. securities laws, the report noted. Reference Link
News For PSTI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for PSTI

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use